Regado Biosciences, Inc. Selects TransPerfect Trial Interactive Platform as its Study Start-Up and eTMF Solution

Published: Oct 21, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK--(BUSINESS WIRE)--TransPerfect, a leading provider of e-clinical solutions to the life sciences industry, today announced that Regado Biosciences has implemented TransPerfect’s Trial Interactive solution to streamline study start-up and electronic trial master file (eTMF) management for its ongoing 500-site Phase III global study (REGULATE-PCI). Trial Interactive is a web-based, 21 CFR Part 11 compliant platform that eliminates the redundancies inherent in paper-based management of clinical trials.

Help employers find you! Check out all the jobs and post your resume.

Back to news